Title:RNA-based Therapeutics: Master Regulator for Bioengineering Systems in Medicine World
Volume: 12
Issue: 2
Author(s): Malika Arora, Parveen Bansal and Richu Singla*
Affiliation:
- Multidisciplinary Research Unit, Indian Council of Medical Research, GGSMC, Faridkot, India
Keywords:
RNA, RNA therapeutics, disease management, biological process, mRNA, drug development.
Abstract: Ribonucleic acid (RNA) and its types have emerged as master regulators of biological
processes and expanded knowledge regarding the role of RNA in the gene expression inside the cell
have dramatically changed the therapeutic strategies in the past few years. RNA has become a focus
for developing novel therapeutic schemes and hence RNA-based therapies, particularly in viral diseases
have become more enthralling and promising. It is due to the fact that RNA offers various advantages
in disease management as it can be edited and customized in its various forms such as secondary
and tertiary structures. Principles and mechanisms regarding RNA therapeutics are well described
in volumes, however, the information regarding long-awaited RNA-based drug development
and potential hurdles as well as barriers in the way is still scattered. In this regard, these agents
are required to overcome a plethora of barriers such as stability of drug targets, immunogenicity,
adequate binding, targeted delivery, etc. to become effective drugs. Most of the trials are changing
their way from in-vitro to in-vivo studies and it is not far away when RNA-based therapeutics will
find their way from bench to bedside. In this communication, the authors give a brief review of important
recent advances in above said domains of miRNA therapeutics.
